ArticleScientific reports2025
Altered expression of LINC03091 and LINC03090 LncRNAs in bipolar disorder: a case-control study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Upregulation of ANRIL and H19 lncRNAs in bipolar disorder: a putative role for miR-339-5p in molecular pathogenesis.Molecular biology reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Long non-coding RNAs (lncRNAs) are widely expressed and play an essential role in gene regulation through various transcriptional and post-transcriptional mechanisms. Recent findings have highlighted the role of lncRNAs in sustaining cellular homeostasis and neurogenesis within the brain. An increasing number of reports have identified dysregulated lncRNAs linked to psychiatric disorders, including bipolar disorder (BD). We analyzed the expression levels of LRRC2-AS1, LINC03091, and LINC03090 lncRNAs in the blood samples of 50 patients with BD and 50 healthy individuals matched by age, sex, and ethnicity. RNA extraction and cDNA synthesis were performed, followed by real-time polymerase chain reaction to quantify lncRNA expression levels. Receiver operating characteristic (ROC) curve analysis was used to assess the biomarker potential. Furthermore, the relationship between gene expression levels and BD comorbidities was explored. Our findings revealed a significant enhancement in LINC03091 and LINC03090 expression in patients with BD compared with healthy subjects (P < 0.0001 and P = 0.02, respectively). However, the expression levels of LRRC2-AS1 was not significant (P = 0.69). ROC curve analysis indicated that LINC03091 (AUC = 0.74, P < 0.0001) and LINC03090 (AUC = 0.64, P = 0.01) expression levels could effectively differentiate patients from healthy controls. Considering these results, LINC03091 and LINC03090 may have a crucial role in BD and could serve as biomarkers for diagnostic and predictive applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.